It indicated that 1-AP and 1-HP were demonstrated to mediate renal fibrosis through activation of the aryl hydrocarbon receptor signaling pathway and the endogenous 1-AP and 1-HP are novel mediators of CKD progression. Here, AHR is linked to chronic kidney disease.